ArticleParasites & vectors2014
Evaluation of a rapid device for serological in-clinic diagnosis of canine angiostrongylosis.
Article in Parasites & vectors, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
41 citing papers in PubMed, 92 citations in OpenAlex.
- Screening of Respiratory Tract-Associated Nematodes in Moroccan Dogs: Focus onVeterinary medicine international · 2026Article
- Increased metallopeptidase activity, compromised endothelial integrity and impaired pathogen recognition revealed by transcriptomics inCurrent research in parasitology & vector-borne diseases · 2026Article
- High prevalence of vector-borne pathogens in the blood of clinically healthy dogs in Hong Kong.Parasites & vectors · 2025Article
- Epidemiological Mapping of Canine Angiostrongylosis in Portugal: Findings from a Nationwide Prevalence Survey.Veterinary sciences · 2025Article
- Is theFrontiers in veterinary science · 2023Article
- First Report ofPathogens (Basel, Switzerland) · 2022Article
- Comprehensive Map of Canine Angiostrongylosis in Dogs in Spain.Animals : an open access journal from MDPI · 2022Article
- Hemostatic Dysfunction in Dogs Naturally Infected withPathogens (Basel, Switzerland) · 2022Review
- The current situation of Angiostrongylus vasorum in Romania: a national questionnaire-based survey.BMC veterinary research · 2021Article
- Simultaneous Exposure toPathogens (Basel, Switzerland) · 2021Article
- Coagulation Status in Dogs Naturally Infected withPathogens (Basel, Switzerland) · 2021Article
- Article
- Further studies of neuroangiostrongyliasis (rat lungworm disease) in Australian dogs: 92 new cases (2010-2020) and results for a novel, highly sensitive qPCR assay.Parasitology · 2021Article
- Intra Vitam Diagnosis of NeglectedPathogens (Basel, Switzerland) · 2020Article
- Field safety and efficacy of an orally administered combination of sarolaner, moxidectin and pyrantel (Simparica TrioParasites & vectors · 2020Article
- First epidemiological survey of Angiostrongylus vasorum in domestic dogs from Spain.Parasites & vectors · 2020Article
- ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.Journal of veterinary internal medicine · 2020Article
- Is Angiostrongylosis a Realistic Threat for Domestic Cats?Frontiers in veterinary science · 2020Article
- First case of a natural infection in a domestic cat (Felis catus) with the canid heart worm Angiostrongylus vasorum.Veterinary parasitology, regional studies and reports · 2019Article
- The first seroepidemiological survey for Angiostrongylus vasorum in domestic dogs from Romania.Parasites & vectors · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAngiostrongylus vasorum is a potentially fatal canine nematode. Due to the high variability of clinical signs and the often chronic and subtle course of the infections, the diagnosis is particularly challenging. A rapid in-clinic assay (Angio Detect Test, IDEXX Laboratories, Westbrook, Maine, USA) for the serological detection of circulating antigen and intended for routine in-clinic diagnosis has been evaluated.
methodsSensitivity was calculated with sera from 39 naturally infected dogs confirmed by Baermann-Wetzel analysis, while sera of 38 experimentally infected dogs were used for follow-up analyses, of which 10 were treated with imidacloprid/moxidectin. Cross-reactivity was tested with a total of 123 samples from dogs with proven parasitic infections with Toxocara canis (n = 21), Ancylostoma caninum (n = 4), Crenosoma vulpis (n = 18), Oslerus osleri (n = 3), Eucoleus aerophilus, (n = 6), Dirofilaria immitis (n = 28), Dirofilaria repens (n = 20), Acantocheilonema reconditum (n = 10) or Dipetalonema dracunculoides (n = 10) or multiple infections (n = 3). All sera were tested with the Angio Detect Test and with an ELISA for detection of circulating antigen of A. vasorum.
resultsThe sensitivity of the Angio Detect Test was 84.6% (95% C.I. 69.5 - 94.1%), while specificity was 100% (95% C.I. 97.6 - 100%). The sensitivity of the ELISA (94.9%, 95% C.I. 82.7 - 99.3%) was comparable with previous evaluations. In experimentally infected dogs, earliest positive results with the Angio Detect Test were observed 9 weeks post inoculation and 5 weeks later all sera were Angio Detect Test positive. After anthelmintic treatment, seropositive dogs turned negative again within 3 to 7 weeks after treatment. The evaluation of the colour intensity of the test strips confirmed the delay of approximately 3-4 weeks for antigen detection by the Angio Detect™ Test compared to the ELISA and its correlation with the time after infection.
conclusionsThis study provided evidence of a good sensitivity and a very high specificity of the rapid device Angio Detect Test for detection of circulating A. vasorum antigen in dogs with suspected canine angiostrongylosis, representing a very simple and useful tool to be broadly applied in veterinary practices. The rapid detection of infected dogs is a key point for initiating an indispensable and urgent therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.